Grantham, Mayo, Van Otterloo & Co (GMO)’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$509K Buy
12,970
+2,079
+19% +$80.3K ﹤0.01% 597
2026
Q2
$397K Sell
10,891
-291
-3% -$9.18K ﹤0.01% 584
2026
Q1
$313K Buy
11,182
+5,811
+108% +$191K ﹤0.01% 590
2025
Q4
$201K Buy
+5,371
New +$177K ﹤0.01% 635

Other funds holding HRMY

Grantham, Mayo, Van Otterloo & Co (GMO)'s HRMY Position: Q3 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Harmony Biosciences (HRMY) stake by 19% in Q3 2026, buying an estimated $80.3K and bringing the position to 12,970 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #597.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HRMY in Q4 2025 and has held it in 4 quarters since. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 12,970 shares of Harmony Biosciences worth $509K as of Q3 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 2,079 Harmony Biosciences shares in Q3 2026, an estimated $80.3K.
  • Harmony Biosciences made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q3 2026, its #597 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Harmony Biosciences in Q4 2025 and has held it in 4 quarters since.
  • 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.